In summary, the effects of fecal enzyme activity on glucose, insulin, and incretin levels are complex and multifaceted, and a better understanding of these effects can induce the development of new approaches to manage glucose metabolism and metabolic disorders. This evidence concerns the gene GCG and metabolic disease.